AI in genomics market size was estimated at US$ 497.92 million in 2022 it is predicted to grow at a CAGR of 46.04% from 2023 to 2032 to reach around US$ 21,972.42 million by the end of 2032.
The AI in genomics market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global AI in genomics market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global AI in genomics market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40072
Report Scope of the AI In Genomics Market
| Report Coverage | Details |
| Market Size in 2022 | USD 497.92 million |
| Revenue Forecast by 2032 | USD 21,972.42 million |
| Growth rate from 2023 to 2032 | CAGR of 46.04% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | IBM; Microsoft Corporation; NVIDIA Corporation; DEEP GENOMICS; Data4Cure, Inc.; Freenome Holdings, Inc.; Thermo Fisher Scientific; Illumina, Inc.; SOPHiA GENETICS; BenevolentAI; Fabric Genomics |
This study covers an elaborate segmentation of the global AI in genomics market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global AI in genomics market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
AI In Genomics Market Segmentations:
| By Component | By Technology | By Functionality | By Application | By End-use |
| Hardware
Software Services |
Machine Learning
Computer Vision |
Genome Sequencing
Gene Editing Others |
Drug Discovery & Development
Precision Medicine Diagnostics Others |
Pharmaceutical and Biotech Companies
Healthcare Providers Research Centers Others |
Research Methodology
The research methodology acquire by analysts for assemble the global AI in genomics market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global AI in genomics market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on AI In Genomics Market
5.1. COVID-19 Landscape: AI In Genomics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global AI In Genomics Market, By Component
8.1. AI In Genomics Market, by Component, 2023-2032
8.1.1. Hardware
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global AI In Genomics Market, By Technology
9.1. AI In Genomics Market, by Technology, 2023-2032
9.1.1. Machine Learning
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Computer Vision
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global AI In Genomics Market, By Functionality
10.1. AI In Genomics Market, by Functionality, 2023-2032
10.1.1. Genome Sequencing
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Gene Editing
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global AI In Genomics Market, By Application
11.1. AI In Genomics Market, by Application, 2023-2032
11.1.1. Drug Discovery & Development
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Precision Medicine
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Diagnostics
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global AI In Genomics Market, By End-use
12.1. AI In Genomics Market, by End-use, 2023-2032
12.1.1. Pharmaceutical and Biotech Companies
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Healthcare Providers
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Research Centers
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global AI In Genomics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Component (2020-2032)
13.1.2. Market Revenue and Forecast, by Technology (2020-2032)
13.1.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.1.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Forecast, by End-use (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Component (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.7. Market Revenue and Forecast, by End-use (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Component (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Technology (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.1.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.8.5. Market Revenue and Forecast, by End-use (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Component (2020-2032)
13.2.2. Market Revenue and Forecast, by Technology (2020-2032)
13.2.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.2.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.5. Market Revenue and Forecast, by End-use (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Component (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.2.7. Market Revenue and Forecast, by Application (2020-2032)
13.2.8. Market Revenue and Forecast, by End-use (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Component (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Technology (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.2.10. Market Revenue and Forecast, by Application (2020-2032)
13.2.11. Market Revenue and Forecast, by End-use (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Component (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Technology (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.13. Market Revenue and Forecast, by End-use (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Component (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Technology (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.15. Market Revenue and Forecast, by End-use (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Component (2020-2032)
13.3.2. Market Revenue and Forecast, by Technology (2020-2032)
13.3.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.3.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.5. Market Revenue and Forecast, by End-use (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Component (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.7. Market Revenue and Forecast, by End-use (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Component (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.9. Market Revenue and Forecast, by End-use (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Component (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Technology (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End-use (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Component (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Technology (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Component (2020-2032)
13.4.2. Market Revenue and Forecast, by Technology (2020-2032)
13.4.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.4.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Component (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.7. Market Revenue and Forecast, by End-use (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Component (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.9. Market Revenue and Forecast, by End-use (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Component (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Technology (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Component (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Technology (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End-use (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Component (2020-2032)
13.5.2. Market Revenue and Forecast, by Technology (2020-2032)
13.5.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.5.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.5. Market Revenue and Forecast, by End-use (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Component (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.7. Market Revenue and Forecast, by End-use (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Component (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Technology (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Functionality (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 14. Company Profiles
14.1. IBM
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Microsoft Corporation
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. NVIDIA Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. DEEP GENOMICS
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Data4Cure, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Freenome Holdings, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Thermo Fisher Scientific
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Illumina, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. SOPHiA GENETICS
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Benevolent AI
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168